Trump’s Malaria Drug Found Ineffective In US Study

CNBC reports:

Hydroxychloroquine, a decades-old malaria drug touted by President Donald Trump, didn’t appear to help hospitalized patients with Covid-19, according to a new observational study published Thursday in the New England Journal of Medicine.

The study, funded by the National Institutes of Health and conducted by researchers at New York-Presbyterian Hospital and Columbia University Irving Medical Center in New York City, looked at 1,376 consecutive patients who showed up at the emergency room with symptoms of coronavirus.

The new findings come two weeks after the Food and Drug Administration warned consumers against chloroquine or hydroxychloroquine to treat Covid-19 outside a hospital or formal clinical trial setting.